This grant is for supporting promising early-stage investigators in the field of genetics or epigenetics of substance use disorders. The NIDA Avenir Award Program aims to foster future leaders by funding highly innovative research projects, particularly from those who may not yet have the extensive preliminary data typically required for an R01 grant. This program seeks high-impact studies that demonstrate significant potential, enabling researchers to explore novel concepts and make substantial contributions to understanding the genetic and epigenetic underpinnings of substance use disorders. It provides a unique opportunity for talented scientists to pursue groundbreaking ideas and establish their independent research careers, ultimately advancing the future of addiction science.
Opportunity ID: 344139
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | PAR-23-021 |
Funding Opportunity Title: | Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Grant |
Category of Funding Activity: | Education Health |
Category Explanation: | – |
Expected Number of Awards: | – |
Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Oct 21, 2022 |
Last Updated Date: | Oct 21, 2022 |
Original Closing Date for Applications: | Sep 25, 2025 |
Current Closing Date for Applications: | Sep 25, 2025 |
Archive Date: | Oct 31, 2025 |
Estimated Total Program Funding: | – |
Award Ceiling: | $300,000 |
Award Floor: | – |
Eligibility
Eligible Applicants: | State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Special district governments Independent school districts County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
Agency Name: | National Institutes of Health |
Description: | Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. |
Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-021.html |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
Version | Modification Description | Updated Date |
---|---|---|
Related Documents
There are no related documents on this grant.
Packages
Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
FORMS-G | Use for due dates on or before January 24, 2023 | PKG00277384 | Aug 25, 2023 | Jan 24, 2023 | View | |
FORMS-H | Use for due dates on or before January 24, 2025 | PKG00278528 | Aug 25, 2023 | Jan 24, 2025 | View | |
FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289360 | Dec 03, 2024 | Sep 25, 2025 | View |
Package 1
Mandatory forms
344139 RR_SF424_5_0-5.0.pdf
344139 PerformanceSite_4_0-4.0.pdf
344139 RR_OtherProjectInfo_1_4-1.4.pdf
344139 RR_KeyPersonExpanded_4_0-4.0.pdf
344139 PHS398_CoverPageSupplement_5_0-5.0.pdf
344139 PHS398_ResearchPlan_5_0-5.0.pdf
344139 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344139 PHS_AssignmentRequestForm_4_0-4.0.pdf
344139 RR_Budget10_3_0-3.0.pdf
344139 RR_SubawardBudget10_30_3_0-3.0.pdf
344139 PHS398_ModularBudget_1_2-1.2.pdf
Package 2
Mandatory forms
344139 RR_SF424_5_0-5.0.pdf
344139 PerformanceSite_4_0-4.0.pdf
344139 RR_OtherProjectInfo_1_4-1.4.pdf
344139 RR_KeyPersonExpanded_4_0-4.0.pdf
344139 PHS398_CoverPageSupplement_5_0-5.0.pdf
344139 PHS398_ResearchPlan_4_0-4.0.pdf
344139 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344139 PHS_AssignmentRequestForm_3_0-3.0.pdf
344139 RR_Budget10_3_0-3.0.pdf
344139 RR_SubawardBudget10_30_3_0-3.0.pdf
344139 PHS398_ModularBudget_1_2-1.2.pdf
Package 3
Mandatory forms
344139 RR_SF424_5_0-5.0.pdf
344139 PerformanceSite_4_0-4.0.pdf
344139 RR_OtherProjectInfo_1_4-1.4.pdf
344139 RR_KeyPersonExpanded_4_0-4.0.pdf
344139 PHS398_CoverPageSupplement_5_0-5.0.pdf
344139 PHS398_ResearchPlan_5_0-5.0.pdf
344139 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344139 PHS_AssignmentRequestForm_3_0-3.0.pdf
344139 RR_Budget10_3_0-3.0.pdf
344139 RR_SubawardBudget10_30_3_0-3.0.pdf
344139 PHS398_ModularBudget_1_2-1.2.pdf